https://www.selleckchem.com/pr....oducts/etomoxir-na-s
6% between the PN Panel and culture; however, all bacterial targets reported as 105 CFU/mL in culture were reported as ≥105 genomic copies/mL by the PN Panel. Viral targets were identified by the PN Panel in 17.7% of specimens tested, of which 39.1% were detected in conjunction with a bacterial target. A review of patient medical records, including clinically prescribed antibiotics, revealed the potential for antibiotic adjustment in 70.7% of patients based on the PN Panel result, including discontinuation or de-escalation